Clinical Studies

Developing new treatments is important for continually improving patient care. Please click on the following links to learn more about KalVista's KONFIDENT clinical trial:

KVD900-301 (KONFIDENT Study) is a Phase 3 clinical trial to evaluate sebetralstat for the on-demand treatment of hereditary angioedema (HAE) attacks.